Buonomo OC - Search Results

1

Global mapping of cancers: The Cancer Genome Atlas and beyond.

Ganini C, Amelio I, Bertolo R, Bove P, Buonomo OC, Candi E, Cipriani C, Di Daniele N, Juhl H, Mauriello A, Marani C, Marshall J, Melino S, Marchetti P, Montanaro M, Natale ME, Novelli F, Palmieri G, Piacentini M, Rendina EA, Roselli M, Sica G, Tesauro M, Rovella V, Tisone G, Shi Y, Wang Y, Melino G. Ganini C, et al. Among authors: buonomo oc. Mol Oncol. 2021 Nov;15(11):2823-2840. doi: 10.1002/1878-0261.13056. Epub 2021 Jul 20. Mol Oncol. 2021. PMID: 34245122 Free PMC article. Review.

2

From Patient Reported Outcome Measure (PROM) to Environment Related Outcome Measure (EROM): Towards "Green Breast Surgery".

Vanni G, Materazzo M, Pellicciaro M, Marino D, Buonomo OC. Vanni G, et al. Among authors: buonomo oc. In Vivo. 2023 Jul-Aug;37(4):1867-1872. doi: 10.21873/invivo.13278. In Vivo. 2023. PMID: 37369495 Free PMC article.

3

Monoclonal antibodies in the management of carcinoma patients.

Roselli M, Casciani CU, Guadagni F, Buonomo O, Iorio B, Diodati A, Vittorini V, Greiner JW, Colcher D, Schlom J. Roselli M, et al. Med Oncol Tumor Pharmacother. 1991;8(4):223-8. doi: 10.1007/BF02987190. Med Oncol Tumor Pharmacother. 1991. PMID: 1820487 Review.

4

Clinical value of radiolabeled monoclonal antibodies in the management of carcinoma patients.

Roselli M, Guadagni F, Buonomo O, Lombardo A, Diodati A, Vittorini V, Belardi A, Cipriani C, Casciani CU. Roselli M, et al. In Vivo. 1993 Nov-Dec;7(6B):615-21. In Vivo. 1993. PMID: 8193282 Review.

5

Systemic administration of recombinant interferon alfa in carcinoma patients upregulates the expression of the carcinoma-associated antigens tumor-associated glycoprotein-72 and carcinoembryonic antigen.

Roselli M, Guadagni F, Buonomo O, Belardi A, Vittorini V, Mariani-Costantini R, Greiner JW, Casciani CU, Schlom J. Roselli M, et al. J Clin Oncol. 1996 Jul;14(7):2031-42. doi: 10.1200/JCO.1996.14.7.2031. J Clin Oncol. 1996. PMID: 8683233

6

Intraoperative radioimmunolocalization of an anti-CEA MAb F(Ab')2 (FO23C5) in CEA serum-negative colorectal cancer patients.

Roselli M, Guadagni F, Buonomo O, Belardi A, Vittorini V, Cavazzana A, Spagnoli LG, Cipriani C, Casciani CU. Roselli M, et al. Anticancer Res. 1996 Mar-Apr;16(2):883-9. Anticancer Res. 1996. PMID: 8687145

7

Tumor markers as targets for selective diagnostic and therapeutic procedures.

Roselli M, Guadagni F, Buonomo O, Belardi A, Ferroni P, Diodati A, Anselmi D, Cipriani C, Casciani CU, Greiner J, Schlom J. Roselli M, et al. Anticancer Res. 1996 Jul-Aug;16(4B):2187-92. Anticancer Res. 1996. PMID: 8694541 Review.

8

Metabolic findings after liver transplantation within a randomised trial with or without steroids.

Tisone G, Angelico M, Vennarecci G, Palmieri G, Buonomo O, Negrini S, Casciani CU. Tisone G, et al. Transplant Proc. 1998 Jun;30(4):1447-8. doi: 10.1016/s0041-1345(98)00310-8. Transplant Proc. 1998. PMID: 9636587 Clinical Trial. No abstract available.

9

Advantages of Neoral conversion in renal transplant patients.

Vennarecci G, Pisani F, Tisone G, Buonomo O, Famulari A, Casciani CU. Vennarecci G, et al. Minerva Urol Nefrol. 1998 Jun;50(2):161-4. Minerva Urol Nefrol. 1998. PMID: 9707972 Clinical Trial.

10

Novel clinical approaches in monoclonal antibody-based management in colorectal cancer patients: radioimmunoguided surgery and antigen augmentation.

Roselli M, Buonomo O, Piazza A, Guadagni F, Vecchione A, Brunetti E, Cipriani C, Amadei G, Nieroda C, Greiner JW, Casciani CU. Roselli M, et al. Semin Surg Oncol. 1998 Dec;15(4):254-62. doi: 10.1002/(sici)1098-2388(199812)15:4<254::aid-ssu14>3.0.co;2-v. Semin Surg Oncol. 1998. PMID: 9829383 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

142 results

Search Page